GlobeNewswire

Garden centre Plantorama picks Agillic to accelerate data-driven and personalised marketing

Share

Press release, Copenhagen, 1 September 2020

Plantorama, Denmark's largest garden centre offering plants, pets and interior design, has chosen to partner with marketing software company Agillic. Their new marketing automation software will enable them to unleash the next level of data-driven and personalised communication.

"Working with Agillic is a clear upgrade - we had reached a point where our former platform didn’t meet our needs. One of the reasons why we chose Agillic is because it enables us to work with data the way we want to. The flexible and customer-centric data structure is unique to Agillic. We have high ambitions for our data-driven communication – and with Agillic, we don't feel restricted," says Heidi Kørner Bjørn, SoMe manager at Plantorama.

She continues: "We offer high-quality goods, professional advice and inspiration. Our objective is to create excellent customer experiences in our physical shops as well as through our marketing communication. By activating our content in data-driven and personalised communication, in campaigns as well as customer lifecycle flows, we provide extra value to our customers – it is the overall experience and the value-add that sets us apart and creates loyal customers."

Mastering and activating data intelligently is essential to any business today, and to Plantorama the ongoing digital transformation was accelerated during spring 2020. As the COVID-19 pandemic struck, Plantorama sped up their webshop launch to meet the sudden shift in consumer behaviour during the lock-down and keep the business running. Already, webshop data is a valuable source of customer insights that Plantorama can leverage in the daily operations through the Agillic Customer Marketing Platform.

Emre Gürsoy, CEO of Agillic, comments: "We are looking forward to helping Plantorama to boost ROI from their marketing activities as they strengthen their brand and customer experience through personalised communication." He continues:

"Winning Plantorama is part of a trend where we welcome clients that have outgrown their marketing automation solution and are ready for the next level. They are looking for software to increase personalisation, and for many businesses, this also means taking on omnichannel marketing. It all boils down to the ability to leverage data on a strategic and operational level, and there Agillic has a lot to offer."

To help Plantorama onboard smoothly and to ensure a fast time to value, Agillic’s partner, Web2Media, is working closely with Plantorama. Web2Media has also helped Indeks Retail A/S (Bog & Idé, BOGhandleren, Legekæden) and Kop & Kande to implement Agillic. Says Web2Media advisor Jacob Fusager:

"One of our first focus areas is to help Plantorama enable a more comprehensive data collection. By creating additional data fields, we allow a higher degree of relevance and personalisation in communication. I am confident that Plantorama will achieve their business goals with Agillic's sophisticated and highly reliable platform."

For further information, please contact
Emre Gürsoy, CEO, Agillic A/S
+45 3078 4200
emre.gursoy@agillic.com

About Plantorama
Since opening their first garden centre in 1987, Plantorama's range has grown to encompass garden and potted plants, soil and fertiliser, flowerpots, home decor as well as live animals and animal accessories in 11 centres around Denmark. In March 2020, Plantorama opened up a webshop, and in 2021 two new centres are scheduled to open.
www.plantorama.dk

About Agillic A/S
Agillic is a Nordic software company enabling marketers to maximise the use of data and translate it into relevant and personalised communication, establishing strong relations between people and brands. Our customer marketing platform uses AI to enhance the business value of customer communication. By combining data-driven customer insights with the ability to execute personalised communication, we provide our clients with a head start in the battle of winning markets and customers.

Besides the company headquarter in Copenhagen, Agillic has sales offices in London (UK), Stockholm (Sweden), as well as a development unit in Kiev (Ukraine). For further information, please visit www.agillic.com

Agillic A/S Nasdaq First North Copenhagen: AGILC

Gammel Mønt 2 - 1171 Copenhagen K - Denmark


Attachments

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

EPH European Property Holdings Limited (EPH) announces plans to issue and offer up to 4,500,000 new ordinary shares23.11.2020 19:00:00 CETPress release

23 November 2020, Road Town, Tortola, BVI EPH European Property Holdings Ltd (the "Company"), an investment company listed on SIX Swiss Exchange which holds an extensive property portfolio with a total value of around USD 1.3 billion across Europe, announces its intention to issue and offer up to 4,500,000 new ordinary shares for a consideration equaling the last reported net asset value (as per 30 June 2020) in the amount of USD 38.82 per share (the "Offer Shares"). EPH will hold a virtual conference on Monday, 30 November 2020 at 3 pm CET to explain details of the capital increase and the company's strategy. You are welcome to register for this event. Please contact corporatefinance@valartis.chto receive dial-in data. The proceeds from the issue of the Offer Shares will be used for funding our future growth through, including, without limitation, the following: acquisition of additional income generating or to be developed commercial properties and investments in our existing real es

Idorsia announces positive results of the two Japanese registration studies with clazosentan23.11.2020 17:45:10 CETPress release

Clazosentan demonstrates significant reduction of vasospasm-related morbidity and all-cause mortality in patients following aneurysmal subarachnoid hemorrhage (aSAH)Clazosentan demonstrates significant reduction of all-cause morbidity and mortality in patients following aSAH in a pre-planned pooled analysis of data from both studies.Idorsia Japan to file New Drug Application (NDA) with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) in the first half of 2021Global Phase 3 study “REACT” investigating the efficacy and safety of clazosentan for the prevention of clinical deterioration due to vasospasm-related delayed cerebral ischemia in adult patients following aSAH continues to actively recruit Allschwil, Switzerland – November 23, 2020 Idorsia Ltd (SIX: IDIA) today announced positive top-line results of the Japanese registration program investigating clazosentan in adult Japanese patients post-aSAH. The program consisted of two double-blind, randomized, placebo-controlle

Saniona rapporterar positiva topline-resultat från den öppna förlängningen av Fas 2-studien med Tesomet mot hypotalamisk fetma23.11.2020 17:00:00 CETPressemelding

PRESSMEDDELANDE 23 november 2020 Tesomet tolererades väl av patienterna med hypotalamisk fetma under hela den 48 veckor långa studien (24 veckor dubbelblind del följt av 24 veckor öppen förlängning). Inga kliniskt betydelsefulla skillnader kunde noteras avseende hjärtfrekvens eller blodtryck och samtliga patienter som påbörjade den öppna förlängningsstudien slutförde också studien.De patienter som fick Tesomet under hela den 48 veckor långa studietiden påvisades statistiskt signifikanta och kliniskt meningsfulla minskningar av kroppsvikt och midjeomfång från baseline till vecka 48, liksom förbättrad glykemisk kontroll. De förbättringar som observerades under den första dubbelblinda delen av studien bibehölls under hela den senare öppna förlängningsstudien. Även för de patienter som fick placebo under den dubbelblinda delen av studien och sedan Tesomet under den öppna förlängningsstudien påvisades minskningar av kroppsvikt och midjeomfång efter övergången till Tesomet.Saniona kommer att

Saniona Reports Positive Topline Results from Tesomet Phase 2 Open-Label Extension Study in Hypothalamic Obesity23.11.2020 17:00:00 CETPress release

PRESS RELEASE November 23, 2020 Tesomet was well-tolerated in hypothalamic obesity patients throughout the duration of the 48-week trial (24 week double-blind [DB] followed by 24 week open label extension [OLE]), with no clinically meaningful differences in heart rate or blood pressure observed. All patients who entered the OLE study completed it.Patients receiving Tesomet for the full 48 weeks of the study demonstrated statistically significant and clinically meaningful reductions in body weight and waist circumference from baseline to Week 48, as well as improvements in glycemic control. Improvements observed in the DB period of the study were maintained over the duration of the OLE period. Patients who received placebo in the DB period of the study and were subsequently switched to Tesomet for the OLE period also achieved reductions in body weight and waist circumference after being switched to Tesomet.Saniona to host webcast with Dr. Ulla Feldt-Rasmussen on Tuesday, 24 November 202

Incap Corporation: Notification in accordance with chapter 9, section 10 of the securities market act on a change in holdings (Oy Etra Invest Ab)23.11.2020 16:30:00 CETPress release

Incap Corporation Stock Exchange Release 23 November 2020 at 5.30 p.m. (EET) Notification in accordance with Chapter 9, Section 10 of the Securities Market Act on a Change in Holdings (Oy Etra Invest Ab) Incap Corporation has on 23 November 2020 received a notification in accordance with the Securities Market Act, according to which the total holdings of shares and votes of Erkki Etola and the entities controlled by him (Tiiviste-Group Oy and Oy Etra Invest Ab) in Incap Corporation (FI0009006407) has increased over 20 percent threshold. Shareholder: Erkki Etola and entities controlled by him Position of previous notification: 19.20 % out of all shares and votes Date of change in holdings: 20 November 2020 Resulting situation on the date on which threshold was crossed: 1,327,333 shares, i.e. 22.81 % out of all shares and votes Incap Corporation's total number of shares amounts to 5,820,224 and each share has one vote. After November 20, 2020, Erkki Etola's direct holding of shares and v

USD TENDER OPERATION ANNOUNCEMENT23.11.2020 16:20:00 CETPress release

Bid date, 2020-11-25Bid Date2020-11-25Bid times14.00-14.30 (CET/CEST) on the Bid dateOfferent AmountUSD 10 billionMaximum Permitted Volume of BidsUSD 4 billion from an individual institutionSettlement Date2020-11-30Minimum Permitted Bid Volume100 USD million per bidMaximum Allocation40 per cent of the Offerend amountAllocation timeNo later than 15.00 (CET/CEST) on the Bid dateMaturity Date2021-02-22Maximum Number of Bids10 per individual institutionLowest Interest Supplement0,25 percentage pointsConfirmation of bids to e-maileol@riksbank.se Stockholm, 2020-11-23 This is a translation of the special terms and conditions published on riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail.